MLA
Königsbrügge, Oliver, et al. Prevalence of Atrial Fibrillation and Antithrombotic Therapy In Hemodialysis Patients: Cross-sectional Results of the Vienna Investigation of Atrial Fibrillation and Thromboembolism In Patients On Hemodialysis (vivaldi). 2017. https://doi.org/10.17615/fj8s-6g84
APA
Königsbrügge, O., Posch, F., Antlanger, M., Kovarik, J., Klauser Braun, R., Kletzmayr, J., Schmaldienst, S., Auinger, M., Zuntner, G., Lorenz, M., Grilz, E., Stampfel, G., Steiner, S., Pabinger, I., Säemann, M., & Ay, C. (2017). Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI). https://doi.org/10.17615/fj8s-6g84
Chicago
Königsbrügge, Oliver, Florian Posch, Marlies Antlanger, Josef Kovarik, Renate Klauser Braun, Josef Kletzmayr, Sabine Schmaldienst et al. 2017. Prevalence of Atrial Fibrillation and Antithrombotic Therapy In Hemodialysis Patients: Cross-Sectional Results of the Vienna Investigation of Atrial Fibrillation and Thromboembolism In Patients On Hemodialysis (vivaldi). https://doi.org/10.17615/fj8s-6g84